Oncotelic Therapeutics, Inc. (OTLC)

Latest Insider Confidence Score

2026Q1

50.1
Bullish

Company insider confidence (by quarter)

2004Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Kessel Mark Director 27,117,118 Jan 4, 2011
Symphony Capital Partners LP 27,117,118 Aug 12, 2009
Symphony Capital Gp, L.P. 27,117,118 Aug 12, 2009
Symphony Gp, Llc 27,117,118 Aug 12, 2009
SYMPHONY ViDA HOLDINGS LLC 27,117,118 Aug 12, 2009

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 22, 2026 Jan 26, 2026 Trieu Vuong CEO Neutral 52.5 - 0.00% -
Nov 17, 2025 Nov 19, 2025 Trieu Vuong CEO Neutral 52.5 - 0.00% -
Jul 10, 2025 Jul 10, 2025 Trieu Vuong CEO Buy 55.0 +198,737 0.07% $993.7
Jan 29, 2025 Jan 31, 2025 Trieu Vuong CEO Buy 60.0 +346,844 0.30% $9.7K
Nov 22, 2024 Nov 26, 2024 Trieu Vuong CEO Buy 60.0 +298,499 0.26% $8.6K
Aug 23, 2024 Aug 27, 2024 Trieu Vuong CEO Buy 61.3 +500,000 0.43% $10K
Jun 29, 2023 Jun 30, 2023 Trieu Vuong CEO Buy 61.3 +500,000 0.43% $10.9K
Jun 16, 2023 Jun 20, 2023 Trieu Vuong CEO Buy 55.0 +100,000 0.09% $2.6K
Jun 14, 2023 Jun 16, 2023 Trieu Vuong CEO Buy 61.3 +400,000 0.35% $13K
May 26, 2023 May 31, 2023 Trieu Vuong CEO Buy 55.0 +126,888 0.11% $4.3K
May 2, 2023 May 2, 2023 Trieu Vuong CEO Buy 55.0 +100,000 0.09% $4.5K
Dec 6, 2022 Dec 7, 2022 Trieu Vuong CEO Buy 55.0 +120,000 0.11% $6K
Nov 22, 2022 Nov 25, 2022 Trieu Vuong CEO Buy 55.0 +70,000 0.06% $5.6K
Sep 26, 2022 Sep 28, 2022 Trieu Vuong CEO Buy 47.5 +20,000 0.02% $1.4K
Aug 25, 2022 Aug 29, 2022 Trieu Vuong CEO Buy 55.0 +80,000 0.07% $6.6K
Sep 3, 2021 Sep 8, 2021 Trieu Vuong CEO Neutral 52.5 - 0.00% -
Sep 3, 2021 Sep 8, 2021 MAIDA ANTHONY E III Chief Clin. Ops. Officer Neutral 52.5 - 0.00% -
Sep 3, 2021 Sep 8, 2021 KING STEVEN W Director Neutral 52.5 - 0.00% -
Sep 3, 2021 Sep 8, 2021 Saund Saran Chief Business Officer Neutral 52.5 - 0.00% -
Mar 31, 2021 Jul 16, 2021 MAIDA ANTHONY E III CHIEF CLINICAL OFFICER Neutral 52.5 - 0.00% -
Mar 31, 2021 Jul 16, 2021 Trieu Vuong CEO Neutral 60.0 +259,302 0.29% -
Mar 31, 2021 Jul 16, 2021 KING STEVEN W Director Neutral 52.5 - 0.00% -
Jul 8, 2021 Jul 16, 2021 Shah Amit B. CFO Neutral 90.0 +298,837 498.06% -
Jul 8, 2021 Jul 16, 2021 Diamond David Director Neutral 52.5 - 0.00% -
Mar 31, 2021 Jul 16, 2021 Saund Saran CHIEF BUSINESS OFFICER Neutral 67.5 +102,519 0.63% -
Nov 20, 2020 Nov 24, 2020 Shah Amit B. CFO Buy 91.3 +60,000 100.00% $11.6K
Nov 19, 2020 Nov 23, 2020 Park Chulho CHIEF TECHNOLOGY OFFICER Buy 67.5 +22,173 0.79% $4.1K
Nov 19, 2020 Nov 23, 2020 Trieu Vuong CEO Buy 60.0 +50,500 0.25% $9.6K
May 21, 2020 MAIDA ANTHONY E III Director Neutral 52.5 - 0.00% -
May 21, 2020 KING STEVEN W Director Neutral 52.5 - 0.00% -
Mar 26, 2020 Mar 27, 2020 Trieu Vuong CEO Buy 47.5 +3,000 0.02% $360
Feb 10, 2020 Diamond David Director Neutral 52.5 - 0.00% -
May 2, 2019 Trieu Vuong CEO Neutral 52.5 - 0.00% -
May 2, 2019 Uckun Fatih Chief Medical Officer Neutral 52.5 - 0.00% -
May 2, 2019 Hsiao Chao 10% Owner Neutral 52.5 - 0.00% -
May 2, 2019 Hwang Larn 10% Owner Neutral 52.5 - 0.00% -
May 2, 2019 Park Chulho Chief Technical Officer Neutral 52.5 - 0.00% -
Jun 20, 2018 Jun 22, 2018 Schwieterman William D CEO Neutral 52.5 - 0.00% -
Jun 20, 2018 Jun 22, 2018 SANDAGE BOBBY W. JR., PHD. Director Neutral 52.5 - 0.00% -
Jun 20, 2018 Jun 22, 2018 Reynolds Donald Rogers Director Neutral 52.5 - 0.00% -
Jun 20, 2018 Jun 22, 2018 Pedder Simon Director Neutral 52.5 - 0.00% -
Jun 20, 2018 Jun 22, 2018 LOAR MATTHEW M CFO Neutral 52.5 - 0.00% -
Jun 20, 2018 Jun 22, 2018 CHAPLIN DAVID Director Neutral 52.5 - 0.00% -
Apr 12, 2018 Apr 16, 2018 Reynolds Donald Rogers Director Neutral 90.0 +250,000 833.33% -
Apr 12, 2018 Apr 16, 2018 Schwieterman William D CEO Neutral 90.0 +625,000 83668.01% -
Apr 12, 2018 Apr 16, 2018 LOAR MATTHEW M CFO Neutral 90.0 +250,000 500.00% -
Jun 9, 2017 Jun 12, 2017 Pedder Simon Director Neutral 52.5 - 0.00% -
Jun 9, 2017 Jun 12, 2017 SANDAGE BOBBY W. JR., PHD. Director Neutral 52.5 - 0.00% -
Jun 9, 2017 Jun 12, 2017 Reynolds Donald Rogers Director Neutral 52.5 - 0.00% -
Jan 12, 2017 Jan 13, 2017 Schwieterman William D CEO Neutral 52.5 - 0.00% -
Jan 12, 2017 Jan 13, 2017 LOAR MATTHEW M CFO Neutral 52.5 - 0.00% -
Jan 12, 2017 Jan 13, 2017 CHAPLIN DAVID Chief Scientific Officer Neutral 52.5 - 0.00% -
Dec 16, 2016 Dec 20, 2016 Reynolds Donald Rogers Director Buy 91.3 +30,000 100.00% $10.4K
Oct 25, 2016 Oct 27, 2016 SANDAGE BOBBY W PHD Director Neutral 52.5 - 0.00% -
Oct 25, 2016 Oct 27, 2016 Reynolds Donald Rogers Director Neutral 52.5 - 0.00% -
Oct 27, 2016 SANDAGE BOBBY W PHD Director Neutral 52.5 - 0.00% -
Oct 27, 2016 Reynolds Donald Rogers Director Neutral 52.5 - 0.00% -
Jun 1, 2016 Jun 3, 2016 Pedder Simon Director Neutral 52.5 - 0.00% -
Jun 1, 2016 Jun 3, 2016 McMahon Gerald PhD Director Neutral 52.5 - 0.00% -
Jun 1, 2016 Jun 3, 2016 DRISCOLL FREDERICK W Director Neutral 52.5 - 0.00% -
Mar 21, 2016 Apr 19, 2016 Schwieterman William D CEO Neutral 52.5 - 0.00% -
Mar 21, 2016 Mar 23, 2016 CHAPLIN DAVID Chief Scientific Officer Neutral 52.5 - 0.00% -
Mar 21, 2016 Mar 23, 2016 Schwieterman William D CEO Neutral 52.5 - 0.00% -
Mar 21, 2016 Mar 23, 2016 LOAR MATTHEW M CFO Neutral 52.5 - 0.00% -
Mar 21, 2016 Mar 23, 2016 Pedder Simon Director Neutral 52.5 - 0.00% -
Mar 23, 2016 Pedder Simon Director Neutral 52.5 - 0.00% -
Jul 20, 2015 Jul 20, 2015 LOAR MATTHEW M CFO Neutral 52.5 - 0.00% -
Jul 20, 2015 LOAR MATTHEW M CFO Neutral 52.5 - 0.00% -
Jun 12, 2015 Ha Pamela Controller Neutral 52.5 - 0.00% -
May 28, 2015 May 29, 2015 RICHING BARBARA CFO Neutral 52.5 - 0.00% -
May 28, 2015 May 29, 2015 Schwieterman William D CEO Neutral 52.5 - 0.00% -
May 28, 2015 May 29, 2015 HOWSON TAMAR D Director Neutral 52.5 - 0.00% -
May 28, 2015 May 29, 2015 McMahon Gerald PhD Director Neutral 52.5 - 0.00% -
May 28, 2015 May 29, 2015 DRISCOLL FREDERICK W Director Neutral 52.5 - 0.00% -
May 28, 2015 May 29, 2015 CHAPLIN DAVID Chief Scientific Officer Neutral 52.5 - 0.00% -
Jul 2, 2014 Jul 7, 2014 Schwieterman William D Director Neutral 52.5 - 0.00% -
Jul 2, 2014 Jul 7, 2014 McMahon Gerald PhD Director Neutral 90.0 +3,847 26.06% -
Jul 2, 2014 Jul 7, 2014 HOWSON TAMAR D Director Neutral 52.5 - 0.00% -
Jul 2, 2014 Jul 7, 2014 DRISCOLL FREDERICK W Director Neutral 52.5 - 0.00% -
May 30, 2014 May 30, 2014 RICHING BARBARA CFO Neutral 52.5 - 0.00% -
May 15, 2014 May 19, 2014 CHAPLIN DAVID CEO Neutral 52.5 - 0.00% -
Jan 2, 2014 Jan 6, 2014 McMahon Gerald PhD Director Neutral 90.0 +3,584 32.06% -
Jan 2, 2014 Jan 6, 2014 Schwieterman William D Director Neutral 52.5 - 0.00% -
Jan 2, 2014 Jan 6, 2014 HOWSON TAMAR D Director Neutral 52.5 - 0.00% -
Jan 2, 2014 Jan 6, 2014 CHAPLIN DAVID Director Neutral 52.5 - 0.00% -
Jan 6, 2014 DRISCOLL FREDERICK W Director Neutral 52.5 - 0.00% -
Jan 2, 2014 Jan 6, 2014 DRISCOLL FREDERICK W Director Neutral 52.5 - 0.00% -
Aug 8, 2013 Aug 9, 2013 LANGECKER PETER CEO Neutral 90.0 +72,993 1459.86% -
Jul 1, 2013 Jul 2, 2013 Wood Alastair JJ Director Neutral 52.5 - 0.00% -
Jul 1, 2013 Jul 2, 2013 CHAPLIN DAVID Director Neutral 52.5 - 0.00% -
Jul 1, 2013 Jul 2, 2013 Schwieterman William D Director Neutral 52.5 - 0.00% -
Jul 1, 2013 Jul 2, 2013 McMahon Gerald PhD Director Neutral 90.0 +7,407 196.32% -
Jul 1, 2013 Jul 2, 2013 HOWSON TAMAR D Director Neutral 90.0 +3,703 73.21% -
Jun 28, 2013 Jul 1, 2013 LANGECKER PETER CEO Buy 90.0 +3,000 150.00% $8.3K
Jun 25, 2013 Jun 26, 2013 LANGECKER PETER CEO Buy 90.0 +2,000 100.00% $5.6K
Feb 27, 2013 Feb 28, 2013 RICHING BARBARA CFO Neutral 52.5 - 0.00% -
Feb 27, 2013 Feb 28, 2013 LANGECKER PETER CEO Neutral 52.5 - 0.00% -
Jan 23, 2013 Jan 24, 2013 CHAPLIN DAVID Director Neutral 52.5 - 0.00% -
Jan 24, 2013 CHAPLIN DAVID Director Neutral 52.5 - 0.00% -
Jan 2, 2013 Jan 3, 2013 HOWSON TAMAR D Director Neutral 90.0 +1,886 59.46% -